SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, today reported its unaudited financial results for the quarter ended June 30, 2007. Total revenues for the second quarter of 2007 grew to $10.3 million, an increase of more than 60% from the $6.3 million reported for the second quarter of 2006 and an increase of 6% from the $9.7 million recorded in the first quarter of 2007
